Shareholders meeting

Date: 01st September, 2026 National Stock Exchange of India Ltd., Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051. Stock Code: VAISHALI Sub: Notice of 19th Annual General Meeting to be held on Thursday, 24th September, 2026. Dear Sir, Pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 (1) to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations"), please find enclosed herewith the Notice of 19th Annual General Meeting ("AGM") of the Company is scheduled to be held on Thursday, 24th September, 2026 through Video Conferencing and Other Audio-Visual Means (VC/OAVM) At 12:00 P.M. The Notice of the AGM is enclosed herewith which is dispatched to shareholders and also sent to the shareholders of the company on their registered email id and is also made available on the website of the Company viz.: www.vaishalipharma.com. We further wish to inform that pursuant to Section 91 of the Companies Act, 2013 and Regulations 42 of the Listing Regulations, the Register of Members and the Share Transfer Books of the Company will remain closed for the purpose of 19th Annual General Meeting from Friday, 18th September, 2026 to Thursday, 24th September, 2026 (both days inclusive). Kindly take the same on your record. Thanking You, Yours Faithfully, For Vaishali Pharma Limited Vishwa Mekhia Company Secretary Cum Compliance Officer NOTICE OF 19TH ANNUAL GENERAL MEETING Notice is hereby given that the 19th Annual General Meeting (“AGM”) of the Members of Vaishali Pharma Limited (“the Company”) will be held on Thursday, 24th September, 2026 at 12:00 P.M. through Video Conferencing (“VC”) / Other Audio- Visual Means (“OAVM”), to transact the following business. ORDINARY BUSINESS: 1. To receive consider and adopt the Audited Financial Statements of the Company for the Financial Year Ended March 31, 2026 together with the Reports of the Board of Directors and the Auditors thereon; To consider and pass the following resolution as an Ordinary Resolution: “RESOLVED THAT the audited financial statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board and Independent Auditors thereon and together with the Reports of the Board of Directors and the Auditors thereon, as circulated to the members be and are hereby received, considered, approved and adopted.” 2. To appoint a director in place of Mrs. Jagruti Atul Vasani (DIN: 02107094), Whole-Time Director, who retires by rotation and being eligible, offers herself for re-appointment. To consider and pass the following resolution as an Ordinary Resolution: “RESOLVED THAT in accordance with the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, Mrs. Jagruti Atul Vasani (DIN: 02107094), who retires by rotation and being eligible offers herself for re-appointment, be and is hereby re-appointed as Director of the Company liable to retire by rotation.” For and on behalf of the Board of Directors Vaishali Pharma Limited Sd/- Vishwa Mekhia Company secretary & compliance officer Date: 14th August, 2026 Place: Mumbai 19th Annual Report 2025-2026 13 Notes: 1. The Ministry of Corporate Affairs (“MCA”) allows companies to hold AGM through VC/OAVM, without physical presence of Members at a common venue. In compliance with the MCA Circulars, AGM of the Company is being held through VC/OAVM. The Registered Office of the Company, i.e., 706 to 709, 7th Fl, Aravali Busines Center, R. C. Patel Road, Off Sodawala Lane, Borivali West, Mumbai-400092, Maharashtra, India, shall be deemed to be the venue for the AGM. [General Circular Nos. 14/2020 dated April 8, 2020, 17/2020 dated April 13, 2020, 20/2020 dated May 5, 2020 and subsequent circulars issued in this regard, the latest being 03/2025 dated September 22, 2025, collectively referred to as “MCA Circulars”]. 2. In compliance with the provisions of the Companies Act, 2013 (“the Act”), SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and MCA Circulars, the 19th Annual General Meeting (“Meeting” or “AGM”) of the Company is being held through VC / OAVM on Thursday, 24th September, 2026 at 12:00 P.M. The proceedings of the AGM shall be deemed to be conducted at the Registered Office of the Company. Pursuant to the provisions of the Act, a Member entitled to attend and vote at the AGM is entitled to appoint a proxy to attend and vote instead of herself and such proxy need not be a Member of the Company. However, since this AGM is being held through VC/OAVM pursuant to the MCA Circulars and applicable SEBI circulars, physical attendance of Members at a common venue has been dispensed with. Accordingly, the facility for appointment of proxies by the Members will not be available for the AGM and hence, the Proxy Form, Attendance Slip and Route Map are not annexed to this Notice. 3. In accordance with the Secretarial Standard - 2 on General Meetings issued by the ICSI read with Clarification / Guidance on applicability of Secretarial Standards - 1 and 2 issued by the ICSI, the proceedings of the AGM through VC / OAVM shall be deemed to be conducted at the Registered Office of the Company at 706 to 709, 7th Fl, Aravali Busines Center, R. C. Patel Road, Off Sodawala Lane, Borivali West, Mumbai-400092, Maharashtra, India. 4. In compliance with the aforesaid MCA circulars and SEBI circular Notice of the AGM along with Annual Report 2025-26 is being sent only through electronic mode to those members whose email addresses are registered with the Company / Depositories. Members may note that the Notice and the Annual Report 2025-26 will also be available on the Company’s website i.e. https://www.vaishalipharma.com/, websites of the stock exchanges i.e. NSE Limited at https://www. nseindia.com/ and on the website of Central Depository Services (India) Limited (CDSL) (agency for providing the Remote e-Voting facility and e-voting system during the Annual General Meeting) i.e. https://www.evotingindia.com/ noticeResults.jsp 5. Additionally, in accordance with Regulation 36 (1) (b) of the Listing Regulations, the Company is also sending a letter to members whose e-mail address is not registered with Company/ Depository Participant providing the exact web-link of Company’s website from where the Annual Report for financial year 2025-26 can be accessed. 6. Members are requested to send all their documents and communications pertaining to shares to Bigshare Services Private Limited, Pinnacle Business Park, Office no S6-2 ,6th floor, Mahakali Caves Road, Next to Ahura Centre, Andheri East, Mumbai, Mumbai-400093, Maharashtra, India. Phone No: 4043 0200, Email Id: investor@bigshareonline.com, Website: www.Bigshareonline.Com for both physical and demat segments of Equity Shares. Please quote on all such correspondence: “Unit – Vaishali Pharma Limited.” For Shareholders queries: Telephone No.: 022 – 4043 0200 Email ID: investor@bigshareonline.com. 7. The remote e-voting will commence on Monday, 21st September, 2026 at 09:00 A.M. (IST) and will end on Wednesday, 23rd September, 2026 at 05:00 P.M. (IST) During this period, Members of the Company holding shares either in physical form or in dematerialised form as on the Cut-off date, i.e. Thursday, 17th September, 2026, may cast their votes electronically. The shareholders will not be able to cast their vote electronically beyond the date and time mentioned above and the remote e-voting module shall be disabled for voting by Central Depository Services (India) Limited (CDSL) thereafter. 8. The Register of Members and Transfer Books of the Company in respect of the Equity Shares of the Company will remain closed from Friday, 18th September, 2026 to Thursday, 24th September, 2026 both days inclusive. 9. The Notice of Annual General Meeting will be sent to the members; whose name appears in the Register of mem [Showing first 8,000 characters — download PDF for full document]